www.expertperspectives.com Open in urlscan Pro
3.23.213.105  Public Scan

Submitted URL: https://cl.s7.exct.net/?qs=45cb71765bd6cea7f3f8b79ca14f72620373f720c19ff65a1a0cfd6cbd0bde833f60fbc7b827111c3a5e790fb494...
Effective URL: https://www.expertperspectives.com/experts/Corey--Cutler
Submission: On October 18 via api from US — Scanned from DE

Form analysis 4 forms found in the DOM

POST /search

<form action="/search" accept-charset="UTF-8" method="post"><input name="utf8" type="hidden" value="✓"><input type="hidden" name="authenticity_token" value="yKddhCkc6bK/1zjfTyQEESbR1MLgKUc3bn96yKalws3ARm3WkdQFbWmbdxTxek1ee+F+JW2dwBpjKSXFmCW3Bw==">
  <input type="text" name="searchField" id="searchField" placeholder="Search the site">
  <input id="searchIcon" alt="" value="Search" name="submit" type="submit">
  <!--<i class="fas fa-angle-right"></i>-->
  <input name="id" value="17" type="hidden">
  <span id="search-close">Cancel</span>
</form>

POST /login

<form action="/login" accept-charset="UTF-8" method="post"><input name="utf8" type="hidden" value="✓"><input type="hidden" name="authenticity_token" value="yKddhCkc6bK/1zjfTyQEESbR1MLgKUc3bn96yKalws3ARm3WkdQFbWmbdxTxek1ee+F+JW2dwBpjKSXFmCW3Bw==">
  <input placeholder="Email Address" type="email" name="session[email]" id="session_email">
  <input placeholder="Password" type="password" name="session[password]" id="session_password">
  <p class="error"></p>
  <button type="submit" class="theme-bg">SIGN IN</button>
</form>

POST /password_resets

<form action="/password_resets" accept-charset="UTF-8" method="post"><input name="utf8" type="hidden" value="✓"><input type="hidden" name="authenticity_token"
    value="yKddhCkc6bK/1zjfTyQEESbR1MLgKUc3bn96yKalws3ARm3WkdQFbWmbdxTxek1ee+F+JW2dwBpjKSXFmCW3Bw==">
  <input placeholder="Last Name" type="text" name="password_reset[last_name]" id="password_reset_last_name">
  <input placeholder="Email Address" type="text" name="password_reset[email]" id="password_reset_email">
  <p class="error"></p>
  <button type="submit" class="theme-bg">RESET MY PASSWORD</button>
</form>

POST /new_user

<form action="/new_user" accept-charset="UTF-8" method="post"><input name="utf8" type="hidden" value="✓"><input type="hidden" name="authenticity_token" value="yKddhCkc6bK/1zjfTyQEESbR1MLgKUc3bn96yKalws3ARm3WkdQFbWmbdxTxek1ee+F+JW2dwBpjKSXFmCW3Bw==">
  <input placeholder="First Name" type="text" name="user[first_name]" id="user_first_name">
  <input placeholder="Last Name" type="text" name="user[last_name]" id="user_last_name">
  <input placeholder="Email Address" type="text" name="user[email]" id="user_email">
  <input placeholder="Password" type="password" name="user[password]" id="user_password">
  <input placeholder="Confirm Password" type="password" name="user[password_confirmation]" id="user_password_confirmation">
  <input type="submit" name="commit" value="Register" class="theme-bg" data-disable-with="Register">
</form>

Text Content

SIGN IN / JOIN
 * Allergy & Immunology
 * Dermatology
 * Neurology
    * Multiple Sclerosis
    * Epilepsy
    * Insomnia
    * Migraine
   
    * Tuberous Sclerosis Complex

 * Oncology
    * CLL
    * GIST
    * Chronic Myeloid Leukemia
    * Multiple Myeloma
   
    * Mantle Cell Lymphoma
    * Metastatic Pancreatic Cancer
    * Prostate Cancer
    * Myeloproliferative Neoplasms
   
    * Non-Small Cell Lung Cancer
    * MDS & AML
    * cGVHD
    * R R DLBCL
   
    * Carcinoid Syndrome

 * Psychiatry
    * Major Depressive Disorder
    * Schizophrenia
    * Tardive Dyskinesia

   
 * MORE
    * Hematology
    * Hepatology
    * Conference Reporter
    * Endocrinology
   
    * Pulmonology
    * Infectious Diseases
    * Osteoporosis
    * Rheumatology

 * SIGN IN / JOIN


ABOUT THE EXPERT


COREY CUTLER,

MD, MPH, FRCPC

Medical Director, Stem Cell Transplantation Program
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Corey Cutler, MD, MPH, FRCPC, is medical director of the Stem Cell
Transplantation Program at the Dana-Farber Cancer Institute and associate
professor of medicine at Harvard Medical School in Boston, MA. Dr Cutler
received his MD from McGill University Faculty of Medicine and Health Sciences
in Montreal, Canada, completed a residency in internal medicine at the Royal
Victoria Hospital in Montreal, and completed fellowship training in hematology,
medical oncology, and stem cell transplantation at the Dana-Farber Cancer
Institute. He earned an MPH degree at the Harvard School of Public Health. 

Dr Cutler’s research focuses on the development of novel methods of acute and
chronic graft-versus-host disease prophylaxis and therapy, as well as decision
theory in stem cell transplantation. He has been a contributing author of more
than 300 peer-reviewed publications and 40 reviews and book chapters. 

Dr Cutler is currently vice president of the American Society for
Transplantation and Cellular Therapy. He is also on the editorial board of the
journal Biology of Blood and Marrow Transplantation. 


CONTRIBUTING ARTICLES

Oncology / cGVHD

Chronic Graft-versus-Host Disease: Current Challenges and Opportunities

expert roundtables by Daniel R. Couriel, MD, MS; Corey Cutler, MD, MPH, FRCP(C);
and Sergio A. Giralt, MD

The treatment and prevention of chronic graft-versus-host disease (cGVHD) have
been unmet medical needs for some time. Renewed scientific interest ...READ MORE

Oncology / cGVHD

Optimizing the Chronic Graft-versus-Host Disease Treatment Paradigm

expert roundtables by Daniel R. Couriel, MD, MS; Corey Cutler, MD, MPH, FRCP(C);
and Sergio A. Giralt, MD

The prevention and treatment of chronic graft-versus-host disease (cGVHD) remain
an unmet need, with steroid-refractory cGVHD representing a partic...READ MORE

Oncology / cGVHD

Tailoring Care to Organ-Specific Manifestations of Chronic Graft-versus-Host
Disease

patient care perspectives by Corey Cutler, MD, MPH, FRCP(C)

The clinical manifestations of chronic graft-versus-host disease (cGVHD) may be
restricted to a single organ or site or they may be widespread, wit...READ MORE

Oncology / cGVHD

Expert Perspectives in Chronic Graft-versus-Host Disease to Cover Key Topics in
cGVHD Treatment

expert perspectives

Expert Perspectives delivers health care providers with insights from key
thought leaders on the latest advancements and current practices in medic...READ
MORE

Oncology / cGVHD

Refractory Chronic Graft-versus-Host Disease: Choosing Immunosuppressive and/or
Immunomodulating Agents

clinical topic updates by Corey Cutler, MD, MPH, FRCP(C)

Patients with chronic graft-versus-host disease (cGVHD) may require modification
of immunosuppression if they have not at least achieved a partial ...READ MORE

Oncology / cGVHD

Chronic Graft-versus-Host Disease: Management and Monitoring Recommendations

expert roundtables by Daniel R. Couriel, MD, MS; Corey Cutler, MD, MPH, FRCP(C);
and Sergio A. Giralt, MD

Most patients with chronic graft-versus-host disease (cGVHD) do not achieve a
durable resolution of disease activity with initial treatment. The us...READ
MORE

Oncology / cGVHD

Targeting the Biology of Chronic Graft-versus-Host Disease

clinical topic updates by Corey Cutler, MD, MPH, FRCP(C)

The manifestations and severity of chronic graft-versus-host disease (cGVHD) are
highly variable and are influenced by cytokines and downstream pat...READ MORE

Oncology / cGVHD

Chronic Graft-versus-Host Disease: Updates on Treatment and Prevention

expert roundtables by Daniel R. Couriel, MD, MS; Corey Cutler, MD, MPH, FRCP(C);
and Sergio A. Giralt, MD

A major recent development in chronic graft-versus-host disease (cGVHD) has been
the emergence of novel treatments that more precisely target the d...READ MORE

Oncology / cGVHD

Targeting Both Inflammation and Fibrosis in Chronic Graft-versus-Host Disease

clinical topic updates by Corey Cutler, MD, MPH, FRCPC

Chronic graft-versus-host disease (cGVHD) involves both inflammatory and
fibrotic pathologies. While most treatments for cGVHD target the
inflammat...READ MORE

Oncology / cGVHD

Atypical Features of Chronic Graft-versus-Host Disease

patient care perspectives by Corey Cutler, MD, MPH, FRCPC

Chronic graft-versus-host disease (cGVHD) may have some atypical manifestations
that have not classically been ascribed to the disease. Efforts to ...READ MORE

Oncology / cGVHD

Advancements in the Management of Chronic Graft-versus-Host Disease

expert roundtables by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and
Edmund K. Waller, MD, PhD, FACP

As the underlying pathways involved in chronic graft-versus-host disease (cGVHD)
are becoming better understood, novel therapies targeting these pa...READ MORE

Oncology / cGVHD

Incorporating Novel and Conventional Agents in Chronic Graft-versus-Host Disease

expert roundtables by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and
Edmund K. Waller, MD, PhD, FACP

The treatment of chronic graft-versus-host disease (cGVHD) now includes novel
systemic therapies in addition to established agents such as corticos...READ
MORE

 * Allergy & Immunology
 * Pediatric Food Allergies

 * Dermatology
 * Plaque Psoriasis

 * Neurology
 * Multiple Sclerosis
 * Epilepsy
 * Insomnia
 * Migraine
 * Tuberous Sclerosis Complex

 * Oncology
 * * CLL
   * Multiple Myeloma
   * Prostate Cancer
   * Metastatic Pancreatic Cancer
   * Mantle Cell Lymphoma
   * Myeloproliferative Neoplasms
   * GIST
   * Non-Small Cell Lung Cancer
   * MDS & AML
   * Chronic Myeloid Leukemia
   * cGVHD
   * R R DLBCL
   * Carcinoid Syndrome

 * Psychiatry
 * Major Depressive Disorder
 * Schizophrenia
 * Tardive Dyskinesia

 * Hematology
 * cITP
 * Sickle Cell Disease

 * More Specialties
 * Hepatology
 * Conference Reporter
 * Endocrinology
 * Pulmonology
 * Infectious Diseases
 * Osteoporosis
 * Rheumatology

© 2019-2022 Expert Perspectives® Privacy Policy Terms of Service About Experts

Your California Privacy Rights Do Not Sell My Personal Information




SEARCH EXPERT PERSPECTIVES

Cancel


SIGN IN TO EXPERT PERSPECTIVES



SIGN IN
Forgot password? Create an account


FORGOT YOUR PASSWORD?



RESET MY PASSWORD


CREATE AN ACCOUNT


Roadblock
This ad will close after 5 Continue to site.